- NADPH Oxidases: Insights into Selected Functions and Mechanisms of Action in Cancer and Stem Cells
Magdalena Skonieczna et al, 2017, Oxidative Medicine and Cellular Longevity CrossRef - Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells
Hengqiang Zhao et al, 2017, J. Cell. Mol. Med. CrossRef - Mechanistic Evaluation and Translational Signature of Gemcitabine-induced Chemoresistance by Quantitative Phosphoproteomics Analysis with iTRAQ Labeling Mass Spectrometry
Qingke Duan et al, 2017, Sci Rep CrossRef - Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date review
Eckhard Klieser et al, 2016, WJGP CrossRef - Leptin signaling and cancer chemoresistance: Perspectives
Pierre V Candelaria et al, 2017, WJCO CrossRef - Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL
Androulla Elia et al, 2017, Cell Death Dis CrossRef - Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells
Xu Zhu et al, 2018, Front. Pharmacol. CrossRef - null
Nils Elander et al, 2018 CrossRef - Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells
Deepanshi Dhar et al, 2018, Molecular Carcinogenesis CrossRef - Dual delivery nanoscale device for miR-345 and gemcitabine Co-delivery to treat pancreatic cancer
Uz Metin et al, 2018, Journal of Controlled Release CrossRef - Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
Divya Thomas et al, 2019, Mol Cancer CrossRef - Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer
Srinivasa P Pothula et al, 2016, Br J Cancer CrossRef - FOXO3 is essential for CD44 expression in pancreatic cancer cells
M Kumazoe et al, 2017, Oncogene CrossRef - Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
K E Richards et al, 2017, Oncogene CrossRef - Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment
Tessa Ya Sung Le Large et al, 2019, Ther Adv Med Oncol CrossRef - null
Nils Elander et al, 2017 CrossRef - The ionophore antibiotic gramicidin A inhibits pancreatic cancer stem cells associated with CD47 down-regulation
Rui-Qi Wang et al, 2019, Cancer Cell Int CrossRef - Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies
Murielle Mimeault et al, 2014, Molecular Aspects of Medicine CrossRef - PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic
Anne-Laure Papa et al, 2013, Cell Oncol. CrossRef - Mesenchymal stem cells preserve their stem cell traits after exposure antimetabolite chemotherapy
Ramon Lopez Perez et al, 2019, Stem Cell Research CrossRef - Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133+ pancreatic cancer cells
Koichiro Tsukasa et al, 2015, Human Cell CrossRef - Promising molecular mechanisms responsible for gemcitabine resistance in cancer
Yanfei Jia et al, 2015, Genes & Diseases CrossRef - Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance.
Monish Ram Makena et al, 2019, Int J Mol Sci CrossRef - The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
Pingting Zhou et al, 2017, Mol Cancer CrossRef - PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma
Motofumi Kumazoe et al, 2017, Sci Rep CrossRef - The FOXO3/PGC-1β signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma
Motofumi Kumazoe et al, 2017, J. Biol. Chem. CrossRef - Attenuation of hedgehog/GLI signaling by NT1721 extends survival in pancreatic cancer.
Claudia M Kowolik et al, 2019, J Exp Clin Cancer Res CrossRef - Establishment and Characterization of Paired Primary Cultures of Human Pancreatic Cancer Cells and Stellate Cells Derived from the Same Tumor
Manoj Amrutkar et al, 2020, Cells CrossRef - Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker
Yosep Chong et al, 2020, BMC Cancer CrossRef - Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications.
Xiewan Chen et al, 2017, Oncotarget CrossRef - Functions of pancreatic stellate cell-derived soluble factors in the microenvironment of pancreatic ductal carcinoma
Qi Wu et al, 2017, Oncotarget CrossRef - Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer
Srinivasa P. Pothula et al, 2017, Oncotarget CrossRef - Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models
Martina D'Aronzo et al, 2015, Oncotarget CrossRef - Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment
Agnieszka A. Rucki et al, 2017, Mol Cancer Ther CrossRef - CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer
Yong-Jian Deng et al, 2014, Clin Cancer Res CrossRef - Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery
Huang-Chiao Huang et al, 2018, Cancer Res CrossRef - Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells
Michael Timaner et al, 2018, Cancer Res CrossRef - Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence
Petra Sántha et al, 2021, Cancers CrossRef - The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
Yibo Fu et al, 2021, Cells CrossRef - The Role of the Hedgehog Pathway in Chemoresistance of Gastrointestinal Cancers
Yabing Liang et al, 2021, Cells CrossRef - Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies
Haipeng Zhu et al, 2021, Front. Oncol. CrossRef - M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
Yongmei Zhao et al, 2021, Pharmaceutics CrossRef - CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells
Khalid Rashid et al, 2021, Cancers CrossRef - Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus
Dakota W. Goad et al, 2022, Molecular Therapy - Oncolytics CrossRef - SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression
Estefania Carrasco-Garcia et al, 2022, Cancers CrossRef - microRNA-497 prevents pancreatic cancer stem cell gemcitabine resistance, migration, and invasion by directly targeting nuclear factor kappa B 1
Qiangfeng Yu et al, 2022, Aging CrossRef - Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma
Manoj Amrutkar et al, 2022, Molecular Oncology CrossRef - Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC)
Alessandro Gregori et al, 2023, Cancers CrossRef - Clinical Significance of Overexpression of Oct4 in Advanced Stage Gallbladder Carcinoma
Deepika Singh et al, 2023, J Gastrointest Canc CrossRef - Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC)
Md Maksudul Alam et al, 2023, Oncotarget CrossRef - microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer
Naotake Funamizu et al, 2023, Cancers CrossRef - Co-delivery of gemcitabine and Triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer
Yongmei Zhao et al, 2023, International Journal of Pharmaceutics CrossRef - Chemomodulatory Effect of the Marine-Derived Metabolite “Terrein” on the Anticancer Properties of Gemcitabine in Colorectal Cancer Cells
Reham Khaled Abuhijjleh et al, 2023, Marine Drugs CrossRef - PPAR/PDK4 pathway is involved in the anticancer effects of cGMP in pancreatic cancer
Mai Yamashita et al, 2023, Biochemical and Biophysical Research Communications CrossRef - HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis
Alpha Raj Mekapogu et al, 2023, Cancer Letters CrossRef - 1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1
Daniela Carbone et al, 2023, Marine Drugs CrossRef - Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer
Xiaowei Wang et al, 2024, Journal of Controlled Release CrossRef - Stepwise optimization of tumor-targeted dual-action platinum(iv)-gemcitabine prodrugs
Alexander Kastner et al, 2024, Inorg. Chem. Front. CrossRef - Molecular analysis of XPO1 inhibitor and gemcitabine–nab‐paclitaxel combination in KPC pancreatic cancer mouse model
Md. Hafiz Uddin et al, 2023, Clinical & Translational Med CrossRef - Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
Masahiro Uehara et al, 2024, Cancer Drug Resist CrossRef - Pharmacological mechanisms underlying the interaction of the nucleoside analogue gemcitabine with the c-MET inhibitor tivantinib in pancreatic cancer
Mahrou Vahabi et al, 2024, Nucleosides, Nucleotides & Nucleic Acids CrossRef - The nuclear export protein exportin‐1 in solid malignant tumours: From biology to clinical trials
Chuanxi Lai et al, 2024, Clinical & Translational Med CrossRef - Hedgehog Signaling in Cancer: A Prospective Therapeutic Target for Eradicating Cancer Stem Cells.
Ita Novita Sari et al, 2018, Cells CrossRef - Role of Wnt/β-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumors.
Charudatt Samant et al, 2024, Biochem Biophys Res Commun CrossRef - Characterization of equilibrative nucleoside transport of the pancreatic cancer cell line: Panc-1
Sila Appak Baskoy et al, 2023, tjps CrossRef - Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
Tomas Koltai et al, 2022, Cancers CrossRef - Unravelling the complexities of resistance mechanism in pancreatic cancer: insights from in vitro and ex-vivo model systems
Giulia Lencioni et al, 2024, Seminars in Cancer Biology CrossRef - Prediction of synergistic gemcitabine-based combination treatment through a novel tumor stemness biomarker NANOG in pancreatic cancer
Jiongjia Cheng et al, 2024, RSC Med. Chem. CrossRef - Correlation Between Antihypertensive Drugs and Survival Among Patients with Pancreatic Ductal Adenocarcinoma
Natalia Kluz et al, 2024, Cancers CrossRef - Improved Antitumor Efficiency of N4-Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy
Dan Wang et al, 2024, IJN CrossRef